Home
Tags
molecular diagnostics

molecular diagnostics

Breakthrough studies in hematopathology will be presented at the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo, taking place November 11–15 in Boston.

New Research in Blood Cancer Diagnostics to Be Featured at AMP 2025

Association for Molecular Pathology

Studies reveal faster, more precise genetic testing tools for acute myeloid leukemia

Closing the Diagnostic Gap in CNS Infections

Delve Bio

Metagenomic next-generation sequencing helps clinical labs diagnose meningitis and encephalitis faster, supporting timely and informed treatment decisions

Elevated levels of lipoprotein(a) are strongly linked to a higher risk of heart attack, stroke, and aortic valve disease.

Predictive Lab Test for Cardiac Events Still Rare but Increasing

University of California - San Diego

Analysis of 300 million patient records shows only 0.2 percent of the US population has been tested for lipoprotein(a)

Photo of the Roche cobas® 5800, 6800, and 8800 systems.

FDA Clears First TAGS-Powered Respiratory Panel for Simultaneous Detection of SARS-CoV-2, Flu, and RSV

Roche

Cleared for use on Roche’s cobas® systems, the new PCR test supports syndromic respiratory diagnostics with customizable panels and digital reflex capability

“The ADLM 2025 program spotlights the sweeping scope of laboratory medicine in solving the most pressing problems of our time,” said ADLM CEO Mark J. Golden.

ADLM 2025 to Address Medical Misinformation, Health Risks Posed by Plastics, AI Integration into Care, Precision Medicine, and More

Association for Diagnostics and Laboratory Medicine

This year’s meeting, in partnership with CSCC, explores clinical AI, medical misinformation, plastics in health, and advances in genomics and microbiome medicine

While gliomas are the major cause of cancer-related death in adolescents and young adults, there are distinct differences between gliomas that occur in children versus older adults, and treatment can vary depending on someone’s age at diagnosis.

Molecular Testing Unveils New Insights into Adolescent and Young Adult Brain Cancer

The Hospital for Sick Children

Specialized molecular testing helps shape potential treatments for patients with glioma

Traditional quality assurance programs focus only on analytical accuracy, leaving a gap in ensuring that the results are precise and actionable for patient care. The Molecular EQA program goes beyond just accuracy to also evaluate report clarity, how quickly results are delivered, and the result interpretation.

The Future of Pathology: Integrating Molecular EQA for Improved Cancer Care

Sofia Ramirez

The Molecular EQA program ensures that biomarker testing meets the highest standards of accuracy and reliability, supporting proficiency testing as an important part of medical laboratory practice

Photo of the main sign at the U.S. FDA Headquarters, White Oak Campus, showing buildings and trees in the background.

FDA Declines to Appeal Court Ruling on LDT Oversight

Today's Clinical Lab, Association for Molecular Pathology

AMP President Jane S. Gibson, PhD, affirms the court ruling calling it a win for patients, innovation, and molecular pathology

PROSTOXTM ultra is the first and only molecular diagnostic test to use biology and genetics to predict radiation toxicity

New Study Validates First and Only Molecular Diagnostic Test for Radiation Toxicity in Prostate Cancer

MiraDx

PROSTOX ultra is the first and only molecular diagnostic test to use biology and genetics to predict radiation toxicity

iStock

The Missing Factor in Reliable Sequencing: Fragmentation Control

Today's Clinical Lab

Small changes in fragmentation lead to significant shifts in data quality. See the comparison